The single-mode fiber optic cable market consists of sales of single-mode fiber optic cables and related services that are used in various applications such as in data centers, community antenna televisions, military, telecommunication and networking, factory automation, and industrial networking. Single-mode optical fiber is an optical fiber designed to carry a single mode of light as a carrier that is used for long-distance signal transmission.

A biocomposite refers to a reinforced compound made from mixing a natural resin and a reinforcing compound. They are environmentally friendly and can be recycled easily. Biocomposites are used as an alternative to non-biodegradable polymers in various industries such as automotive, packaging, food and beverages. The main types of biocomposites market products are hybrid biocomposites and green biocomposites. Hybrid biocomposites are used in construction, medicine, electronics, packaging, and automotive. Hybrid biocomposites are composites made from more than one type of reinforcement matrices. The polymers used are natural polymer composites and synthetic polymer composites. The fiber types are wood fiber composites and non-wood fiber composites. The various end-use industries are building and construction, transportation, consumer goods, and other end-use industries. The biocomposites market research report is one of a series of new reports from The Business Research Company that provides biocomposites market statistics, including biocomposites industry global market size, regional shares, competitors with biocomposites market share, detailed biocomposites market segments, market trends and opportunities, and any further data you may need to thrive in the biocomposites industry. This biocomposites market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global biocomposites market size grew from $24.68 billion in 2022 to $29.42 billion in 2023 at a compound annual growth rate (CAGR) of 19.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The biocomposites market size is expected to grow to $54.68 billion in 2027 at a CAGR of 16.8%. Growing environmental concerns are expected to propel the growth of the biocomposites market going forward. Environmental concerns refer to environmental issues that affect human activity in the biophysical environment, which causes harmful environmental degradation. Biocomposites have fewer environmental footprints, and they are safer for humans and other living habitats. Also, most biocomposites are recyclable and reusable. For instance, according to Mastercard, a US-based financial services company, in 2021, a survey was conducted in 24 countries with a sample size of 25,519 adults to know the consumer's passion for the environment. In this survey, 83% of adults stated that they are taking personal action on environmental and sustainability issues. Also, in generation Z, 36% are two times more aware of environmental and sustainable issues. 58% of the adult respondents were more conscious of their impact on the environment. As a result, growing environmental concerns are driving the growth of the biocomposites market. Technological innovations are the key trend gaining popularity in the agricultural textiles market. Major companies operating in the market are in traducing new technologies such as fully biocomposite material Tepex which is manufactured by using continuous fiber-reinforced thermoplastic composites. For instance, in October 2021, Lanxess, a German specialty chemicals company, introduced a new fully biocomposite material in its Tapex range. That acts as the matrix, for a material that is 100% recyclable. By using continuous fiber-reinforced thermoplastic composites. That helps to give lighter weight than glass fibers and make it flexible with lower density and it also offers mechanical performances to Tepex. This material can also be used in the manufacture of interior parts for cars or electronics to produce housing components. In March 2022, CBD Global Sciences Inc., a Canadian specialty pharmaceutical company announced the acquisition of Pure BioPlastics Inc for an undisclosed amount. The acquisition enables CBD Global to create a bio-based technologies division and offer advanced solutions to the worldwide environmental issues dealing with plastics. Pure BioPlastics Inc is a US-based renewable plastics company. Major players in the biocomposites market are UPM, Trex Company Inc., Fiberon LLC, FlexForm Technologies, Universal Forest Products Inc., Nanjing Jufeng Advanced Materials Co Ltd., Meshlin Composites ZRT, Tecnaro GmbH, Lingrove, CG BioComposites, Bcomp Ltd., HempFlax Group B V, Trifilon AB, Stora Enso and Propel Biocomposites. Asia-Pacific was the largest region in the biocomposites market in 2022. North America was the second-largest region in the biocomposites market. The regions covered in the biocomposites market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the biocomposites market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The biocomposites market consists of sales of natural fiber-reinforced biocomposites, basic biocomposites and nanoparticle-reinforced biocomposites. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global biocomposites market is segmented - 1) By Product: Hybrid Biocomposites, Green Biocomposites 2) By Polymer: Natural Polymer Composites, Synthetic Polymer Composites 3) By Fiber Type: Wood Fiber Composites, Non-Wood Fiber Composites 4) By End-Use Industries: Building And Construction, Transportation, Consumer Goods, Others End-Use Industries

Single-use packaging refers to a packaging that is used to provide non-repetitive packaging materials for packaging different commodities and helps to reduce the cost of packaging in industries. Single-use packaging can be recycled easily and it is the packaging of commodities such as food and beverages, pharmaceuticals, personal care and cosmetics, and others with paper, paperboard, plastic, glass, and other materials that are disposable or recyclable. The main products of the single-use packing market are rigid packaging and flexible packaging. Rigid packaging refers to a type of packing which is very strong and unable to bend or be forced out of shape and is not flexible. This packaging offers structure and support for products. These materials include corrugated and paperboard boxes, plastic bottles and boxes, aluminum cans, and glass jars. The various material types include paper and paper board, plastic, glass, and others. It is employed in food, beverage, personal care, pharmaceutical and other end-user industries. The single-use packing market research report is one of a series of new reports from The Business Research Company that provides single-use packing market statistics, including single-use packing industry global market size, regional shares, competitors with a single-use packing market share, detailed single-use packing market segments, market trends and opportunities, and any further data you may need to thrive in the single-use packing industry. This single-use packing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry. The global single-use packaging market size grew from $28.41 billion in 2022 to $30.77 billion in 2023 at a compound annual growth rate (CAGR) of 8.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The single-use packaging market size is expected to grow to $39.98 billion in 2027 at a CAGR of 6.8%. The growing requirement for small-sized and easier-to-carry packages is expected to propel the growth of the single-use packaging market going forward. Small-sized and easier-to-carry packages refer to packaging materials that can be recycled easily. Small-sized and easier-to-carry packages come under single-use packaging that helps with the packing of material. For instance, in 2020, according to the House of Commons Library, a UK-based library and information resource, around 226 million single-use plastic carrier bags were sold in England by major retailers such as Asda, Marks & Spencer, Morrisons, Sainsbury’s, The Co-operative Group, Tesco, and Waitrose. In addition, according to the same report, on average, each person in the population used 4 single-use plastic carrier bags in one week. Therefore, the increasing demand for small-sized and easier-to-carry packages is driving the growth of the single-use packaging market. The emergence of recyclable packaging solutions is the key trend gaining popularity in the single-use packaging market. Major companies operating in the single-use packaging sector are focused on introducing new innovations to meet consumer demand. For instance, in January 2022, Amcor plc., a Switzerland-based manufacturer of single-use packaging materials, launched its paper-based packaging product called AmFiber. AmFiber provides a wide range of recyclable paper-based packaging solutions for snack and confectionery customers that provide a high barrier to oxygen and moisture. In November 2021, Ardagh Group S.A., a Luxembourg-based company operating in single-use packaging products, acquired Consol Holdings Proprietary Limited for a deal amount of $635 million. Through this acquisition, Ardagh Group S.A. aims to offer customers end-to-end services and strengthen its product portfolio in glass packaging, which would lead to gaining a leadership position and expand its reach in the glass packaging market in the African subcontinent. Consol Holdings Proprietary Limited is a South Africa-based company operating in single-use glass packaging, primarily in food and beverages. Major players in the single-use packaging market are Ardagh Group S.A., WINPAK Ltd., SNAPSIL Corporation, Transcontinental Inc., Sealed Air, Amcor PLC, Dart Container Corporation, Zipz Inc., Tetra Pak, Winpak Limited, and Mondi. Asia-Pacific was the largest region in the single use packing market in 2022. The regions covered in the single-use packaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the single-use packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The single-use packaging market consists of sales of disposable and glass packaging. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global single use packaging market is segmented - 1) By Product: Rigid Packaging, Flexible Packaging 2) By Material Type:Paper and Paper Board, Plastic, Glass, Other Material Types 3) By End-User Industry: Food, Beverage, Personal Care, Pharmaceutical, Other End-user Industries

Single-use bioprocessing refers to bioprocessing equipment designed to be used only once and then discarded. These are generally made of plastic components that are sterilized using gamma radiation. It can help save cleaning time, water, and energy consumption. The single-use bioprocessing is used throughout the bioproduction workflow with minimum risk of cross-contamination. The main types of products in single-use bioprocessing market are single-use media bags and containers, single-use assemblies, single-use bioreactors, disposable mixers, and others. Single-use media bags and containers market consists are used for containing sterile media, cell cultures, sera, buffers, and reagents. Single-use media bags and containers are sterile containers that can be only used once and then discarded. The different workflows include upstream, fermentation, and downstream. The various applications are filtration, storage, cell culture, mixing, and purification. It is used by biopharmaceutical and pharmaceutical companies, contract research organizations and contract manufacturing organizations (CROs and CMOs), academic and research institutes. The single-use bioprocessing market research report is one of a series of new reports from The Business Research Company that provides single-use bioprocessing market statistics, including single-use bioprocessing industry global market size, regional shares, competitors with a single-use bioprocessing market share, detailed single-use bioprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the single-use bioprocessing industry. This single-use bioprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global single use bioprocessing market size grew from $18.33 billion in 2022 to $21.88 billion in 2023 at a compound annual growth rate (CAGR) of 19.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The single use bioprocessing market size is expected to grow to $43.78 billion in 2027 at a CAGR of 18.9%. The surge in demand for biopharmaceuticals is expected to propel the growth of the single-use bioprocessing market going forward. Biopharmaceuticals are medicines made from living cells or organisms. Single-use bioprocessing systems are commonly used in biopharmaceutical manufacturing for increasing productivity, saving costs, and safe disposal of waste. For instance, according to a report by the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based pharmaceutical trade association, 2020, biopharmaceutical production in Europe reached $315.8 billion in 2020, up from $298.7 billion in 2019. Therefore, the increasing demand for biopharmaceuticals is driving the growth of the single-use bioprocessing market. Technological advancements are a key trend gaining popularity in the single-use bioprocessing market. Major companies operating in the single-use bioprocessing market are introducing new technologies to sustain their position. For instance, in February 2020, Applikon Biotechnology, a Netherlands-based upstream bioprocess equipment manufacturer, launched the AppliFlex ST lab-scale bioreactor. It is a single-use fully customizable and scalable bioreactor made using 3D printing technology that is uniquely configured to each process, including custom impeller design, inlets, outlets, and various port connections. It helps to provide multiple options, such as impellers in helical, and hydrofoil. In June 2021, Avantor Inc., a US-based chemicals and materials manufacturer acquired RIM Bio for an undisclosed amount. The acquisition would help Avantor to better serve the customers by expanding the single-use manufacturing portfolio in the AMEA region. RIM Bio is a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing. Major players in the single use bioprocessing market are GE Healthcare, Eppendorf AG, Corning Incorporated, Thermo Fisher Scientific Inc., Sartorius AG, JM BioConnect, Merck KGaA, Pall Corporation, Kuhner AG, PBS Biotech Inc., Entegris Inc., Distek Inc., ABEC Inc., Able Corporation, and Biott Corporation, Solida Biotech GmbH, OmniBRx Biotechnologies Pvt Ltd., Satake Chemical Equipment Mfg. Ltd., Stobbe Pharma GmbH, Celltainer Biotech BV, and Cellexus. North America was the largest region in the single-use bioprocessing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single use bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the single use bioprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The single-use bioprocessing market includes revenues earned by entities by bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags and containers, mixing systems, tubing assemblies and sampling systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global single use bioprocessing market is segmented - 1) By Product: Single-Use Media Bags And Containers, Single-Use Assemblies, Single-Use Bioreactors, Disposable Mixers, Other Products. 2) By Workflow: Upstream, Fermentation, Downstream 3) By Application: Filtration, Storage, Cell Culture, Mixing, Purification 4) By End User: Biopharmaceutical And Pharmaceutical companies, Contract Research Organizations And Contract Manufacturing Organizations (CROs and CMOs), Academic and Research Institutes

Single-cell analysis is the study of transcriptomics, genomics, proteomics, cell interactions, and metabolomics at the level of a single cell. It helps in standardizing and automating the workflows with information useful in the treatment of various diseases such as cancer. The single-cell analysis is engaged in conducting research and experimental development in single-cell analysis. The main types of single-cell analysis are consumables and instruments. Consumables are used in exosome analysis, research and genetic exploration, and isolation of RNA and DNA. The workflow of single-cell analysis is single-cell isolation & library preparation, downstream analysis, and data analysis using techniques such as flow cytometry, next-generation sequencing, polymerase chain reaction (PCR), microscopy, mass spectrometry, and other techniques. There are various applications of single-cell analysis such as cancer, immunology, neurology, stem cell, non-invasive prenatal diagnosis, in-vitro fertilization, and other applications. The end-users are academic and research laboratories, biotechnology and pharmaceutical companies, and hospital and diagnostic laboratories. The single-cell analysis market research report is one of a series of new reports from The Business Research Company that provides single-cell analysis market statistics, including single-cell analysis industry global market size, regional shares, competitors with a single-cell analysis market share, detailed single-cell analysis market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell analysis industry. This single-cell analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global single-cell analysis market size grew from $2.9 billion in 2022 to $3.28 billion in 2023 at a compound annual growth rate (CAGR) of 13.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The single-cell analysis market size is expected to grow to $5.62 billion in 2027 at a CAGR of 14.4%. The growing focus on personalized medicine across the globe is contributing to the growth of the single-cell analysis market. Personalized medicine is a medical practice that uses a genetic profile of a particular individual to make decisions for the treatment of a disease and also for the prevention and diagnosis of the disease for that specific individual. The single-cell analysis could help in the treatment of various diseases by giving deep insights into the needs of individual patients, the nature of the disease, and the personalized treatment for it. Thus, more patients are opting for personalized medicines for themselves. For example, according to the survey conducted in July 2021, by Dosis, a dosing platform provider, of 1,000 people, 85% of patients think that personalized medicine will improve care for them and 80% of patients think that personalized medicine should be available for all. Hence, the increasing focus on personalized medicine is supporting the growth of the market. Companies in the single-cell analysis market are focusing on technological advancements to deliver intact and viable single cells. With the help of technological advancements, companies in the market are maintaining sample integrity through shipping, storage, and processing, increasing the recovery rates of delicate cells, and also eliminating the need for specialized instruments. For example, in October 2021, PerkinElmer, a US-based company engaged in diagnostics, food, environmental and industrial testing, and, life science research, along with Honeycomb Biotechnologies, a US-based company involved in single-cell genomic analysis, launched HIVE™ scRNAseq solution which a portable, single-use and handheld device that allows gentle capture, robust storage, and ease in processing for the analysis of single-cell samples. It has RNA-Seq libraries from a variety of cell types, including fragile and labile cells such as granulocytes, nephrons, hepatocytes, and neurons. The HIVE system is simple to use and offers potential for laboratories conducting fundamental, translational, clinical, and preclinical research. In April 2020, Bio-Rad Laboratories, Inc., a US-based company engaged in life science research and clinical diagnostic products, acquired Celsee Inc., for an undisclosed amount. With this acquisition, Bio-Rad Laboratories has extended its presence in single-cell analysis, to offer valuable insights into the diagnosis and treatment of disease. Celsee, Inc., is a US-based provider of instruments and consumables for the detection, isolation, and analysis of single cells. Major players in the market are Becton, Dickinson and Company, Merck KGAA, QIAGEN N.V., Thermo Fisher Scientific Inc., Illumina Inc., Fluidigm Corporation, 10X Genomics, Bio-Rad Laboratories, Novogene Corporation, Agilent Technologies Inc., Sartorius AG, Luminex Corporation, Fluxion Biosciences, and Oxford Nanopore Technologies. North America was the largest region in the single-cell analysis market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the single-cell analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The single-cell analysis market includes revenues earned by entities by providing services such as antibody based methods, fluorescent protein based methods, and mass-spectroscopy based methods. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global single cell analysis market is segmented - 1) By Product: Consumables, Instruments 2) By Workflow: Single-cell Isolation And Library Preparation, Downstream Analysis, Data Analysis 3) By Technique: Flow Cytometry, Next Generation Sequencing, Polymerase Chain Reaction (PCR), Microscopy, Mass Spectrometry, Other Techniques 4) By Application: Cancer, Immunology, Neurology, Stem cell, Non-invasive prenatal diagnosis, In-vitro fertilization, Other Applications 5) By End User: Academic and Research Laboratories, Biotechnology and Pharmaceutical Companies, Hospital and Diagnostic Laboratories

Single-family modular and prefabricated housing construction is the process of building, altering, repairing, improving, or demolishing any single-family residential building or structure developed off-site using the same resources and constructing the same codes and specifications as conventionally designed structures but in about half the time. The main types of single-family modular and prefabricated housing construction are permanent and relocatable houses. A partially or fully assembled building that is created at a building manufacturing facility employing a modular construction technique and meets applicable codes or state standards is referred to as relocatable home construction. Relocatable buildings are intended to be reused or repurposed several times before being transferred to new construction locations. The different materials include steel, wood, concrete, and others and are used in residential, commercial, and industrial applications. The single-family modular and prefabricated housing construction market research report is one of a series of new reports from The Business Research Company that provides single-family modular and prefabricated housing construction market statistics, including single-family modular and prefabricated housing construction industry global market size, regional shares, competitors with a single-family modular and prefabricated housing construction market share, detailed single-family modular and prefabricated housing construction market segments, market trends and opportunities, and any further data you may need to thrive in the single-family modular and prefabricated housing construction industry. This single-family modular and prefabricated housing construction market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global single-family modular and prefabricated housing construction market size will grow from $45.08 billion in 2022 to $47.17 billion in 2023 at a compound annual growth rate (CAGR) of 4.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global single-family modular and prefabricated housing construction market size is expected to grow to $56.76 billion in 2027 at a CAGR of 4.7%. The significant focus on cost savings is a key factor driving the growth of the single-family modular and prefabricated housing construction market. Modular design can minimise project deadlines by as much as 50% and costs by 20%. They lead to increased productivity and lower employment expenses associated with purchasing units along a production line. According to a report on modular construction in Europe and the US, the modular market value in new real-estate construction is expected to reach $130 billion by 2030, delivering an annual cost saving of $20 billion. Therefore, the significant cost savings are expected to drive the growth of the single-family modular and prefabricated housing construction market. The risks associated with transportation are a key factor impacting the growth of the single-family modular and prefabricated housing markets. As modules are prefabricated in a factory away from the worksite, they must either be transported specifically to the construction site or assembled in a surrounding venue and then set up. The transporters and operators must be extremely cautious with each module. If one fails during transportation, the entire module may require major repairs or replacements. So, it is necessary for transport and rigging businesses to make a serious effort to trace the routes and plan the mechanics to transfer the modules along their path. For instance, a construction project in Philadelphia had modular units arrive, positioned, and set relatively smoothly, but the interior drywall was cracked due to the raising of the modules. Implementation of Building Information Modeling (BIM) in modular construction is an emerging trend in the single-family modular and prefabricated housing construction market. Building Information Modeling (BIM) is a revolutionary technique for designing, building, and managing construction models. This 3D model-based technology provides a digital representation of a building's physical and functional qualities. The technology enables all parties engaged in the built asset's creation and lifespan management to share data and collaborate. During the pre-construction phase, BIM provides specialists with a 3D picture of the structure. It allows specialists to detect potential incompatibilities in mechanical, electrical, and plumbing (MEP) systems and address them at an early stage. For instance, in October 2021, AGACAD, a Lithuania-based software company, launched Panel Packer based on 3D technology. In Autodesk Revit, Panel Packer is a sophisticated tool for organising the sorting, packing, and loading of prefabricated construction components. In January 2020, GS Engineering & Construction (E&C), a South Korea-based construction company, acquired Danwood S.A. from Enterprise Investors for a deal amount of $155 million. Through this acquisition, GS E&S planned to enter the European modular housing market by utilising the strength, networks, and technology of Danwood. Danwood S.A. is a Poland-based company that specialises in the construction of timber-framed houses. Major players in the single-family modular and prefabricated housing construction market are Red Sea Housing Services, Skanska AB, Bouygues Construction, ACS Actividades de Construcción y Servicios SA, Lindal Cedar Homes Inc., Kiewit Corporation, Balfour Beatty PLC., Taisei Corporation, System House R & C Co. Ltd., Larsen & Toubro Limited. Asia-Pacific was the largest region in the single-family modular and prefabricated housing construction market in 2022. Eastern Europe is expected to be the fastest-growing region in the global single-family modular and prefabricated housing construction market during the forecast period. The regions covered in the global single-family modular and prefabricated housing construction market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the single-family modular and prefabricated housing construction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The single-family modular and prefabricated housing construction market includes revenues earned by entities by residential structures, residential project construction management firms, and residential design-build firms. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global single-family modular and prefabricated housing construction market is segmented - 1) By Type: Permanent, Re-locatable 2) By Material: Steel, Wood, Concrete, Other Materials 3) By Application: Residential, Commercial, Industrial

Single-chamber prefilled syringes are types of syringes that come with the substance to be injected prefilled. These contain a single type of substance. The main types of products in single-chamber prefilled syringes are glass and plastic. A glass-based single-chamber prefilled syringe is a type of single-chamber prefilled syringe manufactured using glass. Glass is the most preferred material for manufacturing prefilled syringes. A plastic-based single-chamber prefilled syringe uses plastic as the preferred material. These single-chamber prefilled syringes are used for injecting prefilled vaccine products, biological, or pharmaceutical products. The single-chamber prefilled syringes market research report is one of a series of new reports from The Business Research Company that provides single-chamber prefilled syringes market statistics, including single-chamber prefilled syringes industry global market size, regional shares, competitors with a single-chamber prefilled syringes market share, detailed single-chamber prefilled syringes market segments, market trends and opportunities, and any further data you may need to thrive in the single-chamber prefilled syringes industry. This single-chamber prefilled syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global single-chamber prefilled syringes market size grew from $8.57 billion in 2022 to $9.5 billion in 2023 at a compound annual growth rate (CAGR) of 10.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The single-chamber prefilled syringes market size is expected to grow to $14.98 billion in 2027 at a CAGR of 12.1%. The growing prevalence of chronic diseases such as diabetes and cancer is contributing to the growth of the single-chamber prefilled syringes market. Diabetes patients who require insulin therapy when medicines could not control their blood glucose levels, the diabetes patients use the single-chamber prefilled syringe. According to the IDF Diabetes Atlas 2021, an organization that promote diabetes care, prevention, and a cure worldwide, 1 in 10 individuals (20–79 years old) have diabetes, which affects 537 million people. By 2030, this figure is expected to reach 643 million, and by 2045, it will reach 783 million. According to the American Cancer Society, in 2021, 1.9 million new cancer cases would be registered. Therefore, the growing prevalence of chronic diseases such as diabetes and cancers drive the market for single-chamber prefilled syringes. The growing technological advancements are shaping the single-chamber prefilled syringe market. Major companies operating in the single-chamber prefilled syringe sector are focused on developing technological solutions for the single-chamber prefilled syringe market to strengthen their position. For instance, In September 2022, Otsuka America Pharmaceutical, Inc., a US-based healthcare company, and H. Lundbeck A/S, a Danish international pharmaceutical company, introduced Aripiprazole 2-month. It comes in a single-chamber, prefilled syringe and is a 2-month, ready-to-use, long-acting injectable form of aripiprazole. The gluteal muscle is where it is to be injected intramuscularly every two months for the dosage. In October 2020, Credence Medsystems, a US-based drug delivery, and specialty pharmaceutical company has collaborated with Schott AG, a German-based glass and glass-ceramics manufacturing company. The collaboration is to integrate Credence’s Companion technology with Schott’s refillable syringe glass and polymer syringe systems and provide an innovative and differentiated offering for the delivery of injectable medications via prefilled syringes. Major players in the single-chamber prefilled syringes market are BD, Gerresheimer, Schott, Catalent, Nipro, Weigao, Stevanato, Baxter, Vetter Pharma, and Terumo. North America was the largest region in the single-chamber prefilled syringes market in 2022. Asia-Pacific was the second largest region in the single-chamber prefilled syringes market. The regions covered in the single-chamber prefilled syringes report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the single-chamber prefilled syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The single-chamber prefilled syringes market consists of sales of glass and plastic single-chamber prefilled syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global market for single chamber prefilled syringes is divided into segments. 1) By Type: Glass, Plastic 2) By Application: Vaccine Product, Biologic, Pharmaceutical Product 

A single-use bioreactor is a bioreactor that has a disposable bag instead of a culture vessel. Single-use bioreactors permit processors to move to the utilization of disposable technologies, including single-use bags, in assembly steps that had been reserved for stainless steel gear. The main types of single-use bioreactors are stirred-tank SUBs, wave-induced SUBs, bubble-column SUBs, and other types. Stirred tank bioreactor designs that replicate traditionally stirred tank bioreactors have been introduced to the market, gaining more market adoption. The different types of molecules include vaccines, monoclonal antibodies, stem cells, and recombinant proteins and involve various cell types such as mammalian cells, bacteria, and yeast. The various applications involved are research and development, process development, and bioproduction. The several end-users include pharmaceutical and biopharmaceutical companies, contract research organizations (CRO), academic and research institutes, and contract manufacturing organizations (CMO). The single-use bioreactors market research report is one of a series of new reports from The Business Research Company that provides single-use bioreactors market statistics, including single-use bioreactors industry global market size, regional shares, competitors with a single-use bioreactors market share, detailed single-use bioreactors market segments, market trends and opportunities, and any further data you may need to thrive in the single-use bioreactors industry. This single-use bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global single-use bio reactors market size grew from $3.77 billion in 2022 to $4.48 billion in 2023 at a compound annual growth rate (CAGR) of 18.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The single-use bio reactors market size is expected to grow to $8.91 billion in 2027 at a CAGR of 18.8%. The rapid adoption of single-use technologies (SUTs) by the industries is expected to propel the growth of the single-use bioreactors market going forward. Single-use technology (SUT) aids biopharmaceutical manufacturers in eliminating the risk of contamination which is the greatest challenge faced by manufacturers of biopharmaceuticals and increases operational efficiency by reducing or eliminating the need for sterilization between batches. For example, according to the American Pharmaceutical Review, in 2020, single-use bioreactors are used by 71.2% of the industries in process development, and over 55% use single-use sampling systems in clinical or commercial production. Therefore, the rapid adoption of SUTs by the industry is driving the growth of the single-use bioreactor market. Product innovations are a key trend gaining popularity in the single-use bioreactors market. Innovations in technology and the increasing trend of mobile gaming technology are also encouraging market demand. Major companies in the market are focusing on launching innovative products for market growth. For instance, In March 2020, Sartorius, a Germany-based biopharmaceutical company, launched BIOSTAT STR Generation 3 with BIOBRAIN, making biopharmaceutical development and production faster, simpler, and safer. This robust industrial platform contains hardware, software, and consumables for single-use process development and commercial biomanufacturing. Biostat STR bioreactors and Flexsafe STR bags have been ranging from 12.5L to 2000L in the working volume. The system has been powered by BIOBRAIN, a new automation platform that gives biologics manufacturers the flexibility to quickly and easily configure the Biostat STR system to meet their precise needs. In April 2020, Sartorius, a Germany-based pharmaceutical and laboratory equipment supplier, acquired the life science businesses of Danaher Corporation for an undisclosed amount. This acquisition of Danaher life sciences Broadens portfolio for the development and production of biotech medicines. Danaher Corporation is a US-based company that provides single-use bioreactors. Major players in the single-use bio reactors market are CESCO Bioengineering Co. Ltd., PBS Biotech Inc., Solida Biotechnology GmbH, ABEC Inc., Eppendorf AG, Sartorius Stedim Biotech Sa Ltd., Danaher Corporation Ltd., Thermo Fisher Scientific Inc., GE Healthcare, Merck Kgaa (Merck Millipore) Pvt. Ltd., Distek Inc., Celltainer Biotech Bv Pvt.Ltd., Getinge AB, Pall Corporation, G&G Technologies Inc., SATAKE MultiMix Corporation, and Bio-Age Equipment & Service Pvt.Ltd. North America was the largest region in the single use bioreactors market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-use bioreactors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the single-use bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The single-use bioreactors market consists of sales of stirrer single-use bioreactors and rocker single-use bioreactors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global single use bio reactors market is segmented - 1) By Type: Stirred-Tank SUBs, Wave-Induced SUBs, Bubble-Column SUBs, Other Types 2) By Molecule Type: Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins 3) By Cell Type: Mammalian Cell, Bacteria, Yeast 4) By Application: Research And Development (R&D), Process Development, Bioproduction 5) By End User: Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations (CRO), Academic And Research Institutes, Contract Manufacturing Organizations (CMO)